Genetic Technology--Accelerating Drug Discoveries through Protein-based Technique

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This technology opportunity engine (TOE) service, Genetic Technology News, depicts the current landscape and the new life sciences trends across drug discoveries accelerated through protein-based techniques. Special emphasis has been focused on life sciences research through 3D images of megaenzymes and bispecific antibodies, as well as, research collaboration for next generation therapeutics. Relevant advances in Alzheimer's Disease are also profiled through casein kinase delta1 inhibitors. A section with the acute perspective of our analysts through an analysis of patents for novel antibody-based cancer therapies is included. All industry interactions including main contacts are mapped.Keywords: 3D imaging,

Table of Contents

Genetic Technology--Accelerating Drug Discoveries through Protein-based TechniqueTechnology Profiles3D Images of MegaenzymesResearch Collaboration for Next Generation TherapeuticsBispecific Antibodies for EbolaCasein Kinase 1Delta Inhibitors for Decreasing Tau Phosphorylation in Alzheimer's DiseasePatent AnalysisPatent Analysis Patent Analysis (continued)AppendixPatent ScenarioPatent Scenario (continued)Industry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.